Morgan Stanley Initiates Coverage on Heartflow (NASDAQ:HTFL)

Key Points

• Morgan Stanley initiated coverage on Heartflow (NASDAQ:HTFL) with an "equal weight" rating and a target price of $35.00, indicating an expected upside of 11.11% from the current price.
• Multiple analysts, including Canaccord Genuity and JPMorgan Chase, have issued various ratings for Heartflow, with the consensus rating currently being "Moderate Buy" and an average target price of $35.80.
• Heartflow's stock opened at $31.50 and has a 12-month price range between $26.56 and $36.68.

Morgan Stanley started coverage on shares of Heartflow (NASDAQ:HTFL - Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage issued an equal weight rating and a $35.00 price target on the stock.

Several other brokerages also recently weighed in on HTFL. Piper Sandler started coverage on shares of Heartflow in a report on Tuesday, September 2nd. They issued an "overweight" rating and a $38.00 target price for the company. JPMorgan Chase & Co. initiated coverage on shares of Heartflow in a report on Tuesday, September 2nd. They issued an "overweight" rating and a $36.00 target price for the company. Stifel Nicolaus initiated coverage on shares of Heartflow in a report on Tuesday, September 2nd. They set a "buy" rating and a $35.00 price objective for the company. Wall Street Zen raised shares of Heartflow to a "hold" rating in a report on Saturday, August 16th. Finally, Canaccord Genuity Group initiated coverage on shares of Heartflow in a report on Tuesday, September 2nd. They set a "buy" rating and a $35.00 price objective for the company. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $35.80.

Heartflow Stock Down 8.8%

Heartflow stock traded down $3.01 during mid-day trading on Tuesday, hitting $31.07. The stock had a trading volume of 442,043 shares, compared to its average volume of 878,154. Heartflow has a one year low of $26.56 and a one year high of $36.68.

Heartflow Company Profile

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.